Form 4: Vicarious Surgical CEO Adam Sachs Acquires Stock Options
SEC Form 4 Filing
Vicarious Surgical CEO Adam Sachs acquired stock options exercisable for 12,946 shares of Class A Common Stock on June 17, 2024.
Summary
- On June 17, 2024, Adam David Sachs, CEO of Vicarious Surgical Inc., acquired stock options.
- These options allow him to purchase 12,946 shares of Class A Common Stock at an exercise price of $6.86.
- The options vest in equal monthly installments over 48 months, starting June 17, 2024, contingent upon Sachs' continued service.
- Following the transaction, Sachs directly owns 12,946 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral. It reflects standard compensation practices.
Positives
- The CEO's acquisition of stock options could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reporting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company executives and directors.
Stakeholder Impact
- The acquisition of stock options by the CEO could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of the stock option transaction and start of the vesting period. |
| 06/16/2034 | Expiration date of the stock options. |
| 06/18/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.